Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077454
Status:
COMPLETED
Last Update Posted:
2013-06-05
First Post:
2004-02-10
Brief Title:
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Osteosarcoma |
| Previously Treated Childhood Rhabdomyosarcoma |
| Recurrent Childhood Brain Tumor |
| Recurrent Childhood Cerebellar Astrocytoma |
| Recurrent Childhood Cerebral Astrocytoma |
| Recurrent Childhood Ependymoma |
| Recurrent Childhood Malignant Germ Cell Tumor |
| Recurrent Childhood Medulloblastoma |
| Recurrent Childhood Rhabdomyosarcoma |
| Recurrent Childhood Soft Tissue Sarcoma |
| Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor |
| Recurrent Neuroblastoma |
Keywords: